Pandemic Stock Winners Shopify, Peloton and Zoom: Buying Opportunities in 2025?
Werte in diesem Artikel
(0:30) - Are Any of The Pandemic Stock Winners Still Strong Investments Right Now?(4:40) - Tracey's Top Stock Picks For Your Watchlist(24:00) - Episode Roundup: PTON, SHOP, ZM, TWLO, PYPL Podcast@Zacks.com Welcome to Episode #460 of the Zacks Market Edge Podcast.Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.This week, Tracey is going solo to talk about several companies that were pandemic winners. Their shares soared to new highs in 2021 only to take a tumble in the 2022 sell-off.Are they buying opportunities now?Or is the pandemic era truly over?Buying Opportunity in Shopify, Peloton and Zoom?1. Peloton Interactive, Inc. (PTON)Peloton was one of the hottest stocks during the pandemic as people shunned the gyms to work out at home. But shares are now down 94% in the last 5 years.Peloton is a Zacks #1 Rank (Strong Buy) stock. Earnings are expected to rise 123% this year with positive earnings of $0.07. It lost $0.30 a share last year.Should Peloton be on your watch list in 2025 or is this a trap?2. Shopify Inc. (SHOP)Shopify was another big winner during the pandemic, putting together a streak of earnings beats and strong double-digit sales gains. But earnings fell 93.8% in 2022 and the stock fell too.In 2025, however, Shopify has turned it around. Earnings are expected to rise 11.5% in 2025 and another 21% in 2026. Shares of Shopify are up 52.4% year-to-date and are testing the 2021 highs.Shopify trades with a forward price-to-earnings (P/E) ratio of 114. A P/E over 20 is considered expensive.Should growth investors be taking a second look at Shopify in 2025?3. Zoom Communications, Inc. (ZM)Zoom shares took off in the pandemic when people were forced to work from home.Shares of Zoom peaked in 2021. It is down 83.3% over the last 5 years and has only gained 1.4% in 2025.Yet Zoom is cheap. It trades with a forward price-to-earnings (P/E) ratio of 13.7. A P/E ratio under 15 usually indicates value. Earnings are expected to rise 5.2% in fiscal 2026 and 1% in fiscal 2027.Should Zoom be on the radar of value investors in 2025?What Else Should You Know About the Pandemic Winners?Tracey talks about two more pandemic winning stocks on the podcast. Tune in to find out which stocks these are.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Shopify Inc. (SHOP): Free Stock Analysis Report Zoom Communications, Inc. (ZM): Free Stock Analysis Report Peloton Interactive, Inc. (PTON): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Winners
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Winners
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu ZOOM CORP Registered Shs
Analysen zu ZOOM CORP Registered Shs
Keine Analysen gefunden.